NCT00574743View on ClinicalTrials.gov

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Comparison to Mycophenolate Mofetil (MMF) in de Nove Heart Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

January 31, 2002

Primary Completion Date

April 30, 2004

Conditions
Heart Transplantation
Interventions
DRUG

Enteric-coated Mycophenolate Sodium

Trial Locations (9)

1107

Argentina, Buenos Aires

19103

Novartis Pharmaceuticals, Philadelphia

55455

University of Minnesota, Minneapolis

90073

Novartis Investigative site, Los Angeles

Unknown

Site 1: X5000BJH, Córdoba

Novartis Investigative site, Sydney, Australia, Sydney

T6G 2B7

Novartis Investigative, Edmonton

M5G 2C4

Novartis, Toronto

K1H 8L6

Novarits, Ottawa

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY